nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—ESR2—uterine cancer	0.233	0.619	CbGaD
Estramustine—ESR1—uterine cancer	0.144	0.381	CbGaD
Estramustine—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.128	0.46	CbGbCtD
Estramustine—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.114	0.534	CrCrCtD
Estramustine—Testosterone—Progesterone—uterine cancer	0.0993	0.466	CrCrCtD
Estramustine—ESR1—Progesterone—uterine cancer	0.0846	0.305	CbGbCtD
Estramustine—ABCB1—Progesterone—uterine cancer	0.0145	0.0522	CbGbCtD
Estramustine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0131	0.0472	CbGbCtD
Estramustine—ABCB1—Dactinomycin—uterine cancer	0.0115	0.0414	CbGbCtD
Estramustine—CYP3A4—Progesterone—uterine cancer	0.00868	0.0313	CbGbCtD
Estramustine—ABCB1—Etoposide—uterine cancer	0.00649	0.0234	CbGbCtD
Estramustine—ABCB1—Doxorubicin—uterine cancer	0.00442	0.0159	CbGbCtD
Estramustine—CYP3A4—Etoposide—uterine cancer	0.00389	0.014	CbGbCtD
Estramustine—Glucose tolerance decreased—Progesterone—uterine cancer	0.00324	0.0479	CcSEcCtD
Estramustine—Glucose tolerance decreased—Medroxyprogesterone Acetate—uterine cancer	0.00294	0.0434	CcSEcCtD
Estramustine—ESR2—oviduct—uterine cancer	0.00289	0.0757	CbGeAlD
Estramustine—CYP3A4—Doxorubicin—uterine cancer	0.00265	0.00955	CbGbCtD
Estramustine—MAP1A—myometrium—uterine cancer	0.00251	0.0657	CbGeAlD
Estramustine—Thromboembolism—Progesterone—uterine cancer	0.00204	0.0303	CcSEcCtD
Estramustine—ESR1—oviduct—uterine cancer	0.00198	0.0518	CbGeAlD
Estramustine—MAP1A—smooth muscle tissue—uterine cancer	0.0019	0.0497	CbGeAlD
Estramustine—MAP1A—decidua—uterine cancer	0.00186	0.0487	CbGeAlD
Estramustine—Thromboembolism—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.0274	CcSEcCtD
Estramustine—MAP1A—uterus—uterine cancer	0.00163	0.0426	CbGeAlD
Estramustine—Congenital anomaly—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.0229	CcSEcCtD
Estramustine—Developmental delay—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.0229	CcSEcCtD
Estramustine—MAP2—myometrium—uterine cancer	0.00143	0.0373	CbGeAlD
Estramustine—Raised liver function tests—Progesterone—uterine cancer	0.00141	0.0208	CcSEcCtD
Estramustine—Hoarseness—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.0198	CcSEcCtD
Estramustine—MAP1A—female gonad—uterine cancer	0.00133	0.0349	CbGeAlD
Estramustine—MAP1A—vagina—uterine cancer	0.00132	0.0347	CbGeAlD
Estramustine—Embolism venous—Progesterone—uterine cancer	0.00129	0.0191	CcSEcCtD
Estramustine—Hypernatraemia—Progesterone—uterine cancer	0.00124	0.0183	CcSEcCtD
Estramustine—Night sweats—Progesterone—uterine cancer	0.0012	0.0178	CcSEcCtD
Estramustine—Embolism venous—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.0173	CcSEcCtD
Estramustine—Hypernatraemia—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.0166	CcSEcCtD
Estramustine—MAP2—uterine cervix—uterine cancer	0.00111	0.0291	CbGeAlD
Estramustine—MAP2—decidua—uterine cancer	0.00106	0.0277	CbGeAlD
Estramustine—Embolism—Progesterone—uterine cancer	0.00101	0.015	CcSEcCtD
Estramustine—MAP2—endometrium—uterine cancer	0.001	0.0263	CbGeAlD
Estramustine—Raised liver function tests—Dactinomycin—uterine cancer	0.000995	0.0147	CcSEcCtD
Estramustine—Myelosuppression—Dactinomycin—uterine cancer	0.00098	0.0145	CcSEcCtD
Estramustine—MAP2—mammalian vulva—uterine cancer	0.00097	0.0254	CbGeAlD
Estramustine—Embolism—Medroxyprogesterone Acetate—uterine cancer	0.000918	0.0136	CcSEcCtD
Estramustine—MAP1A—lymph node—uterine cancer	0.000855	0.0224	CbGeAlD
Estramustine—Hypercalcaemia—Medroxyprogesterone Acetate—uterine cancer	0.000848	0.0125	CcSEcCtD
Estramustine—MAP2—female reproductive system—uterine cancer	0.000831	0.0218	CbGeAlD
Estramustine—MAP2—female gonad—uterine cancer	0.000756	0.0198	CbGeAlD
Estramustine—MAP2—vagina—uterine cancer	0.000751	0.0197	CbGeAlD
Estramustine—Tenderness—Progesterone—uterine cancer	0.000745	0.011	CcSEcCtD
Estramustine—ESR2—epithelium—uterine cancer	0.000725	0.019	CbGeAlD
Estramustine—ESR2—uterine cervix—uterine cancer	0.000719	0.0188	CbGeAlD
Estramustine—Dysphonia—Medroxyprogesterone Acetate—uterine cancer	0.000716	0.0106	CcSEcCtD
Estramustine—Myelosuppression—Etoposide—uterine cancer	0.000709	0.0105	CcSEcCtD
Estramustine—ESR2—smooth muscle tissue—uterine cancer	0.000698	0.0183	CbGeAlD
Estramustine—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.000675	0.00999	CcSEcCtD
Estramustine—ESR2—renal system—uterine cancer	0.000672	0.0176	CbGeAlD
Estramustine—ESR2—endometrium—uterine cancer	0.00065	0.017	CbGeAlD
Estramustine—ESR1—myometrium—uterine cancer	0.000633	0.0166	CbGeAlD
Estramustine—ESR2—uterus—uterine cancer	0.000599	0.0157	CbGeAlD
Estramustine—Cramps of lower extremities—Progesterone—uterine cancer	0.000597	0.00884	CcSEcCtD
Estramustine—Thromboembolism—Epirubicin—uterine cancer	0.000586	0.00868	CcSEcCtD
Estramustine—Thrombophlebitis—Progesterone—uterine cancer	0.000545	0.00807	CcSEcCtD
Estramustine—Thromboembolism—Doxorubicin—uterine cancer	0.000543	0.00803	CcSEcCtD
Estramustine—Cramps of lower extremities—Medroxyprogesterone Acetate—uterine cancer	0.000541	0.00801	CcSEcCtD
Estramustine—ESR2—female reproductive system—uterine cancer	0.000538	0.0141	CbGeAlD
Estramustine—Libido decreased—Progesterone—uterine cancer	0.000509	0.00753	CcSEcCtD
Estramustine—Hot flush—Progesterone—uterine cancer	0.000505	0.00747	CcSEcCtD
Estramustine—Menopausal symptoms—Progesterone—uterine cancer	0.0005	0.0074	CcSEcCtD
Estramustine—ESR1—epithelium—uterine cancer	0.000496	0.013	CbGeAlD
Estramustine—Thirst—Progesterone—uterine cancer	0.000496	0.00734	CcSEcCtD
Estramustine—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.000494	0.00731	CcSEcCtD
Estramustine—ESR1—uterine cervix—uterine cancer	0.000492	0.0129	CbGeAlD
Estramustine—ESR2—female gonad—uterine cancer	0.00049	0.0128	CbGeAlD
Estramustine—ESR2—vagina—uterine cancer	0.000487	0.0128	CbGeAlD
Estramustine—MAP2—lymph node—uterine cancer	0.000486	0.0127	CbGeAlD
Estramustine—ESR1—smooth muscle tissue—uterine cancer	0.000478	0.0125	CbGeAlD
Estramustine—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.000472	0.00698	CcSEcCtD
Estramustine—ESR1—decidua—uterine cancer	0.000469	0.0123	CbGeAlD
Estramustine—Disturbance in sexual arousal—Progesterone—uterine cancer	0.000468	0.00693	CcSEcCtD
Estramustine—Affect lability—Progesterone—uterine cancer	0.000465	0.00687	CcSEcCtD
Estramustine—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.000461	0.00682	CcSEcCtD
Estramustine—ESR1—renal system—uterine cancer	0.00046	0.0121	CbGeAlD
Estramustine—Hot flush—Medroxyprogesterone Acetate—uterine cancer	0.000457	0.00676	CcSEcCtD
Estramustine—Menopausal symptoms—Medroxyprogesterone Acetate—uterine cancer	0.000453	0.00671	CcSEcCtD
Estramustine—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.000449	0.00665	CcSEcCtD
Estramustine—Mood swings—Progesterone—uterine cancer	0.000447	0.00662	CcSEcCtD
Estramustine—ESR1—endometrium—uterine cancer	0.000445	0.0117	CbGeAlD
Estramustine—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.000436	0.00646	CcSEcCtD
Estramustine—Liver function test abnormal—Progesterone—uterine cancer	0.000436	0.00645	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.000424	0.00628	CcSEcCtD
Estramustine—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.000421	0.00623	CcSEcCtD
Estramustine—Estriol—ESR2—uterine cancer	0.000416	0.124	CrCbGaD
Estramustine—ESR1—uterus—uterine cancer	0.00041	0.0108	CbGeAlD
Estramustine—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.000405	0.00599	CcSEcCtD
Estramustine—Myelosuppression—Epirubicin—uterine cancer	0.000398	0.00588	CcSEcCtD
Estramustine—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.000392	0.0058	CcSEcCtD
Estramustine—Abdominal discomfort—Progesterone—uterine cancer	0.000391	0.00579	CcSEcCtD
Estramustine—Quinestrol—ESR1—uterine cancer	0.000388	0.116	CrCbGaD
Estramustine—Embolism venous—Epirubicin—uterine cancer	0.000369	0.00547	CcSEcCtD
Estramustine—ESR1—female reproductive system—uterine cancer	0.000369	0.00967	CbGeAlD
Estramustine—Myelosuppression—Doxorubicin—uterine cancer	0.000368	0.00544	CcSEcCtD
Estramustine—Depression—Progesterone—uterine cancer	0.000363	0.00537	CcSEcCtD
Estramustine—Hypernatraemia—Epirubicin—uterine cancer	0.000355	0.00525	CcSEcCtD
Estramustine—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000354	0.00524	CcSEcCtD
Estramustine—Embolism venous—Doxorubicin—uterine cancer	0.000342	0.00506	CcSEcCtD
Estramustine—Lethargy—Dactinomycin—uterine cancer	0.00034	0.00504	CcSEcCtD
Estramustine—ESR1—female gonad—uterine cancer	0.000336	0.0088	CbGeAlD
Estramustine—ESR1—vagina—uterine cancer	0.000334	0.00874	CbGeAlD
Estramustine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.000329	0.00486	CcSEcCtD
Estramustine—Hypernatraemia—Doxorubicin—uterine cancer	0.000328	0.00485	CcSEcCtD
Estramustine—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.000325	0.00481	CcSEcCtD
Estramustine—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.000323	0.00478	CcSEcCtD
Estramustine—Estropipate—ESR2—uterine cancer	0.000318	0.0948	CrCbGaD
Estramustine—Skin exfoliation—Etoposide—uterine cancer	0.000318	0.0047	CcSEcCtD
Estramustine—Lacrimation—Epirubicin—uterine cancer	0.000317	0.00469	CcSEcCtD
Estramustine—ESR2—lymph node—uterine cancer	0.000315	0.00826	CbGeAlD
Estramustine—Liver function test abnormal—Dactinomycin—uterine cancer	0.000308	0.00456	CcSEcCtD
Estramustine—Tinnitus—Progesterone—uterine cancer	0.000304	0.0045	CcSEcCtD
Estramustine—Mestranol—ESR1—uterine cancer	0.000294	0.0876	CrCbGaD
Estramustine—Lacrimation—Doxorubicin—uterine cancer	0.000293	0.00434	CcSEcCtD
Estramustine—Embolism—Epirubicin—uterine cancer	0.00029	0.0043	CcSEcCtD
Estramustine—Alopecia—Progesterone—uterine cancer	0.000289	0.00427	CcSEcCtD
Estramustine—Flatulence—Progesterone—uterine cancer	0.00028	0.00414	CcSEcCtD
Estramustine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.000276	0.00408	CcSEcCtD
Estramustine—Pancytopenia—Dactinomycin—uterine cancer	0.000274	0.00405	CcSEcCtD
Estramustine—Muscle spasms—Progesterone—uterine cancer	0.000273	0.00404	CcSEcCtD
Estramustine—Embolism—Doxorubicin—uterine cancer	0.000269	0.00398	CcSEcCtD
Estramustine—Hypercalcaemia—Epirubicin—uterine cancer	0.000268	0.00397	CcSEcCtD
Estramustine—Cardiac failure congestive—Etoposide—uterine cancer	0.000266	0.00394	CcSEcCtD
Estramustine—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000261	0.00387	CcSEcCtD
Estramustine—CYP3A4—renal system—uterine cancer	0.000257	0.00673	CbGeAlD
Estramustine—Estriol—ESR1—uterine cancer	0.000256	0.0764	CrCbGaD
Estramustine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000254	0.00376	CcSEcCtD
Estramustine—ABCB1—myometrium—uterine cancer	0.00025	0.00655	CbGeAlD
Estramustine—Hypercalcaemia—Doxorubicin—uterine cancer	0.000248	0.00367	CcSEcCtD
Estramustine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000248	0.00366	CcSEcCtD
Estramustine—Chest pain—Progesterone—uterine cancer	0.000242	0.00358	CcSEcCtD
Estramustine—Anxiety—Progesterone—uterine cancer	0.000241	0.00357	CcSEcCtD
Estramustine—Oedema—Progesterone—uterine cancer	0.000232	0.00343	CcSEcCtD
Estramustine—Cardiac arrest—Etoposide—uterine cancer	0.00023	0.0034	CcSEcCtD
Estramustine—Ethinyl Estradiol—ESR2—uterine cancer	0.000227	0.0677	CrCbGaD
Estramustine—Dysphonia—Epirubicin—uterine cancer	0.000227	0.00335	CcSEcCtD
Estramustine—Anorexia—Progesterone—uterine cancer	0.000221	0.00327	CcSEcCtD
Estramustine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00324	CcSEcCtD
Estramustine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00323	CcSEcCtD
Estramustine—ESR1—lymph node—uterine cancer	0.000216	0.00565	CbGeAlD
Estramustine—Flushing—Dactinomycin—uterine cancer	0.000214	0.00317	CcSEcCtD
Estramustine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00021	0.00311	CcSEcCtD
Estramustine—Insomnia—Progesterone—uterine cancer	0.00021	0.0031	CcSEcCtD
Estramustine—Dysphonia—Doxorubicin—uterine cancer	0.00021	0.0031	CcSEcCtD
Estramustine—ESR2—Ovarian Infertility Genes—CDKN1B—uterine cancer	0.000208	0.00886	CbGpPWpGaD
Estramustine—Dyspnoea—Progesterone—uterine cancer	0.000207	0.00306	CcSEcCtD
Estramustine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000206	0.00305	CcSEcCtD
Estramustine—CYP3A4—female reproductive system—uterine cancer	0.000206	0.00539	CbGeAlD
Estramustine—Alopecia—Dactinomycin—uterine cancer	0.000204	0.00302	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000203	0.00866	CbGpPWpGaD
Estramustine—Lacrimation increased—Epirubicin—uterine cancer	0.000202	0.00299	CcSEcCtD
Estramustine—Decreased appetite—Progesterone—uterine cancer	0.000202	0.00298	CcSEcCtD
Estramustine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.0002	0.00296	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000199	0.00848	CbGpPWpGaD
Estramustine—Conjugated Estrogens—ESR2—uterine cancer	0.000199	0.0592	CrCbGaD
Estramustine—Pancytopenia—Etoposide—uterine cancer	0.000198	0.00293	CcSEcCtD
Estramustine—Estrone—ESR2—uterine cancer	0.000198	0.059	CrCbGaD
Estramustine—Estropipate—ESR1—uterine cancer	0.000196	0.0584	CrCbGaD
Estramustine—ABCB1—epithelium—uterine cancer	0.000196	0.00514	CbGeAlD
Estramustine—ABCB1—uterine cervix—uterine cancer	0.000194	0.0051	CbGeAlD
Estramustine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00019	0.00281	CcSEcCtD
Estramustine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000187	0.00277	CcSEcCtD
Estramustine—Lacrimation increased—Doxorubicin—uterine cancer	0.000187	0.00277	CcSEcCtD
Estramustine—ABCB1—decidua—uterine cancer	0.000185	0.00485	CbGeAlD
Estramustine—Acute coronary syndrome—Etoposide—uterine cancer	0.000183	0.00271	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000183	0.00781	CbGpPWpGaD
Estramustine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000183	0.0027	CcSEcCtD
Estramustine—Myocardial infarction—Etoposide—uterine cancer	0.000182	0.0027	CcSEcCtD
Estramustine—ESR1—LKB1 signaling events—STK11—uterine cancer	0.000182	0.00777	CbGpPWpGaD
Estramustine—ABCB1—renal system—uterine cancer	0.000182	0.00477	CbGeAlD
Estramustine—Leukopenia—Dactinomycin—uterine cancer	0.00018	0.00266	CcSEcCtD
Estramustine—Skin exfoliation—Epirubicin—uterine cancer	0.000178	0.00263	CcSEcCtD
Estramustine—ABCB1—endometrium—uterine cancer	0.000176	0.00461	CbGeAlD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—uterine cancer	0.000176	0.00749	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000175	0.00747	CbGpPWpGaD
Estramustine—Cramps of lower extremities—Epirubicin—uterine cancer	0.000171	0.00253	CcSEcCtD
Estramustine—ABCB1—mammalian vulva—uterine cancer	0.00017	0.00446	CbGeAlD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine cancer	0.000166	0.00707	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—uterine cancer	0.000165	0.00703	CbGpPWpGaD
Estramustine—Skin exfoliation—Doxorubicin—uterine cancer	0.000165	0.00244	CcSEcCtD
Estramustine—Pruritus—Progesterone—uterine cancer	0.000164	0.00243	CcSEcCtD
Estramustine—Oedema—Dactinomycin—uterine cancer	0.000164	0.00243	CcSEcCtD
Estramustine—ABCB1—uterus—uterine cancer	0.000162	0.00425	CbGeAlD
Estramustine—ESR1—Regulation of Telomerase—IRF1—uterine cancer	0.000161	0.00688	CbGpPWpGaD
Estramustine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000161	0.00238	CcSEcCtD
Estramustine—Diarrhoea—Progesterone—uterine cancer	0.000159	0.00235	CcSEcCtD
Estramustine—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000158	0.00234	CcSEcCtD
Estramustine—Thrombophlebitis—Epirubicin—uterine cancer	0.000156	0.00231	CcSEcCtD
Estramustine—Anorexia—Dactinomycin—uterine cancer	0.000156	0.00231	CcSEcCtD
Estramustine—Testosterone—CYP11A1—uterine cancer	0.000156	0.0465	CrCbGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000155	0.00663	CbGpPWpGaD
Estramustine—Flushing—Etoposide—uterine cancer	0.000155	0.00229	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000154	0.00656	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—YWHAE—uterine cancer	0.000151	0.00643	CbGpPWpGaD
Estramustine—Estradiol—ESR2—uterine cancer	0.00015	0.0447	CrCbGaD
Estramustine—Eye pain—Epirubicin—uterine cancer	0.00015	0.00222	CcSEcCtD
Estramustine—Cardiac failure congestive—Epirubicin—uterine cancer	0.000149	0.00221	CcSEcCtD
Estramustine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000149	0.0022	CcSEcCtD
Estramustine—Alopecia—Etoposide—uterine cancer	0.000148	0.00218	CcSEcCtD
Estramustine—Vomiting—Progesterone—uterine cancer	0.000148	0.00218	CcSEcCtD
Estramustine—Rash—Progesterone—uterine cancer	0.000146	0.00216	CcSEcCtD
Estramustine—Dermatitis—Progesterone—uterine cancer	0.000146	0.00216	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	0.000146	0.00623	CbGpPWpGaD
Estramustine—ABCB1—female reproductive system—uterine cancer	0.000146	0.00382	CbGeAlD
Estramustine—Headache—Progesterone—uterine cancer	0.000145	0.00215	CcSEcCtD
Estramustine—Hot flush—Epirubicin—uterine cancer	0.000145	0.00214	CcSEcCtD
Estramustine—Thrombophlebitis—Doxorubicin—uterine cancer	0.000145	0.00214	CcSEcCtD
Estramustine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.00213	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—BIRC5—uterine cancer	0.000144	0.00613	CbGpPWpGaD
Estramustine—Menopausal symptoms—Epirubicin—uterine cancer	0.000143	0.00212	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000143	0.00612	CbGpPWpGaD
Estramustine—Decreased appetite—Dactinomycin—uterine cancer	0.000143	0.00211	CcSEcCtD
Estramustine—Ethinyl Estradiol—ESR1—uterine cancer	0.00014	0.0417	CrCbGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	0.00014	0.00597	CbGpPWpGaD
Estramustine—Muscle spasms—Etoposide—uterine cancer	0.00014	0.00207	CcSEcCtD
Estramustine—Eye pain—Doxorubicin—uterine cancer	0.000139	0.00205	CcSEcCtD
Estramustine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000138	0.00204	CcSEcCtD
Estramustine—Lethargy—Epirubicin—uterine cancer	0.000138	0.00204	CcSEcCtD
Estramustine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000138	0.00204	CcSEcCtD
Estramustine—Nausea—Progesterone—uterine cancer	0.000138	0.00204	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000135	0.002	CcSEcCtD
Estramustine—Hot flush—Doxorubicin—uterine cancer	0.000134	0.00198	CcSEcCtD
Estramustine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000134	0.00198	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000133	0.00568	CbGpPWpGaD
Estramustine—Affect lability—Epirubicin—uterine cancer	0.000133	0.00197	CcSEcCtD
Estramustine—Menopausal symptoms—Doxorubicin—uterine cancer	0.000133	0.00196	CcSEcCtD
Estramustine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000133	0.00196	CcSEcCtD
Estramustine—ABCB1—female gonad—uterine cancer	0.000133	0.00347	CbGeAlD
Estramustine—ESR1—ATF-2 transcription factor network—SOCS3—uterine cancer	0.000132	0.00565	CbGpPWpGaD
Estramustine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000132	0.00196	CcSEcCtD
Estramustine—ABCB1—vagina—uterine cancer	0.000132	0.00345	CbGeAlD
Estramustine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000132	0.00195	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00013	0.00555	CbGpPWpGaD
Estramustine—Leukopenia—Etoposide—uterine cancer	0.00013	0.00193	CcSEcCtD
Estramustine—Cardiac arrest—Epirubicin—uterine cancer	0.000129	0.0019	CcSEcCtD
Estramustine—Mood swings—Epirubicin—uterine cancer	0.000128	0.0019	CcSEcCtD
Estramustine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000128	0.00189	CcSEcCtD
Estramustine—Lethargy—Doxorubicin—uterine cancer	0.000128	0.00189	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000126	0.00538	CbGpPWpGaD
Estramustine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000125	0.00185	CcSEcCtD
Estramustine—Liver function test abnormal—Epirubicin—uterine cancer	0.000125	0.00185	CcSEcCtD
Estramustine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000125	0.00185	CcSEcCtD
Estramustine—Dry skin—Epirubicin—uterine cancer	0.000124	0.00184	CcSEcCtD
Estramustine—Chest pain—Etoposide—uterine cancer	0.000124	0.00183	CcSEcCtD
Estramustine—Affect lability—Doxorubicin—uterine cancer	0.000123	0.00182	CcSEcCtD
Estramustine—Conjugated Estrogens—ESR1—uterine cancer	0.000122	0.0365	CrCbGaD
Estramustine—Estrone—ESR1—uterine cancer	0.000122	0.0364	CrCbGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	0.00012	0.00514	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.00012	0.00513	CbGpPWpGaD
Estramustine—Cardiac arrest—Doxorubicin—uterine cancer	0.000119	0.00176	CcSEcCtD
Estramustine—Mood swings—Doxorubicin—uterine cancer	0.000119	0.00176	CcSEcCtD
Estramustine—Thrombocytopenia—Etoposide—uterine cancer	0.000116	0.00172	CcSEcCtD
Estramustine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000116	0.00171	CcSEcCtD
Estramustine—Dry skin—Doxorubicin—uterine cancer	0.000115	0.0017	CcSEcCtD
Estramustine—Anorexia—Etoposide—uterine cancer	0.000113	0.00167	CcSEcCtD
Estramustine—Diarrhoea—Dactinomycin—uterine cancer	0.000112	0.00166	CcSEcCtD
Estramustine—Pancytopenia—Epirubicin—uterine cancer	0.000111	0.00164	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	0.000111	0.00472	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00011	0.00468	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—SOCS3—uterine cancer	0.000109	0.00466	CbGpPWpGaD
Estramustine—Dyspnoea—Etoposide—uterine cancer	0.000106	0.00157	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	0.000105	0.00447	CbGpPWpGaD
Estramustine—Vomiting—Dactinomycin—uterine cancer	0.000104	0.00154	CcSEcCtD
Estramustine—Rash—Dactinomycin—uterine cancer	0.000103	0.00153	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—SMAD3—uterine cancer	0.000103	0.00441	CbGpPWpGaD
Estramustine—Decreased appetite—Etoposide—uterine cancer	0.000103	0.00153	CcSEcCtD
Estramustine—Pancytopenia—Doxorubicin—uterine cancer	0.000103	0.00152	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	0.000102	0.00437	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000102	0.00437	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	9.84e-05	0.0042	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	9.83e-05	0.00419	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	9.76e-05	0.00417	CbGpPWpGaD
Estramustine—Nausea—Dactinomycin—uterine cancer	9.74e-05	0.00144	CcSEcCtD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	9.69e-05	0.00413	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—CDKN2A—uterine cancer	9.52e-05	0.00406	CbGpPWpGaD
Estramustine—Estradiol—ESR1—uterine cancer	9.25e-05	0.0276	CrCbGaD
Estramustine—ESR2—Gene Expression—PHF1—uterine cancer	9.24e-05	0.00394	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	9.04e-05	0.00386	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	8.99e-05	0.00383	CbGpPWpGaD
Estramustine—ESR1—Estrogen signaling pathway—PIK3CA—uterine cancer	8.86e-05	0.00378	CbGpPWpGaD
Estramustine—Tinnitus—Epirubicin—uterine cancer	8.73e-05	0.00129	CcSEcCtD
Estramustine—Flushing—Epirubicin—uterine cancer	8.69e-05	0.00129	CcSEcCtD
Estramustine—ABCB1—lymph node—uterine cancer	8.52e-05	0.00223	CbGeAlD
Estramustine—Pruritus—Etoposide—uterine cancer	8.4e-05	0.00124	CcSEcCtD
Estramustine—ESR1—Signaling by ERBB4—PGR—uterine cancer	8.3e-05	0.00354	CbGpPWpGaD
Estramustine—Alopecia—Epirubicin—uterine cancer	8.27e-05	0.00122	CcSEcCtD
Estramustine—ESR1—FOXA1 transcription factor network—CDKN1B—uterine cancer	8.12e-05	0.00346	CbGpPWpGaD
Estramustine—Diarrhoea—Etoposide—uterine cancer	8.12e-05	0.0012	CcSEcCtD
Estramustine—Tinnitus—Doxorubicin—uterine cancer	8.08e-05	0.0012	CcSEcCtD
Estramustine—Testosterone—CYP19A1—uterine cancer	8.06e-05	0.024	CrCbGaD
Estramustine—Flushing—Doxorubicin—uterine cancer	8.04e-05	0.00119	CcSEcCtD
Estramustine—Flatulence—Epirubicin—uterine cancer	8.03e-05	0.00119	CcSEcCtD
Estramustine—ESR2—Gene Expression—CHD4—uterine cancer	7.86e-05	0.00335	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	7.84e-05	0.00334	CbGpPWpGaD
Estramustine—Muscle spasms—Epirubicin—uterine cancer	7.84e-05	0.00116	CcSEcCtD
Estramustine—Alopecia—Doxorubicin—uterine cancer	7.66e-05	0.00113	CcSEcCtD
Estramustine—Vomiting—Etoposide—uterine cancer	7.55e-05	0.00112	CcSEcCtD
Estramustine—Rash—Etoposide—uterine cancer	7.48e-05	0.00111	CcSEcCtD
Estramustine—Dermatitis—Etoposide—uterine cancer	7.48e-05	0.00111	CcSEcCtD
Estramustine—Headache—Etoposide—uterine cancer	7.43e-05	0.0011	CcSEcCtD
Estramustine—Flatulence—Doxorubicin—uterine cancer	7.43e-05	0.0011	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	7.4e-05	0.00316	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	7.32e-05	0.00312	CbGpPWpGaD
Estramustine—Leukopenia—Epirubicin—uterine cancer	7.3e-05	0.00108	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	7.26e-05	0.00309	CbGpPWpGaD
Estramustine—Muscle spasms—Doxorubicin—uterine cancer	7.25e-05	0.00107	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	7.24e-05	0.00309	CbGpPWpGaD
Estramustine—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	7.13e-05	0.00304	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	7.06e-05	0.00301	CbGpPWpGaD
Estramustine—Nausea—Etoposide—uterine cancer	7.05e-05	0.00104	CcSEcCtD
Estramustine—Chest pain—Epirubicin—uterine cancer	6.94e-05	0.00103	CcSEcCtD
Estramustine—Anxiety—Epirubicin—uterine cancer	6.92e-05	0.00102	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	6.88e-05	0.00294	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—PGR—uterine cancer	6.81e-05	0.00291	CbGpPWpGaD
Estramustine—Leukopenia—Doxorubicin—uterine cancer	6.75e-05	0.000999	CcSEcCtD
Estramustine—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	6.67e-05	0.00285	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	6.67e-05	0.00285	CbGpPWpGaD
Estramustine—Oedema—Epirubicin—uterine cancer	6.65e-05	0.000984	CcSEcCtD
Estramustine—ESR2—Gene Expression—SUZ12—uterine cancer	6.58e-05	0.00281	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	6.58e-05	0.00281	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	6.57e-05	0.0028	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	6.52e-05	0.00278	CbGpPWpGaD
Estramustine—Thrombocytopenia—Epirubicin—uterine cancer	6.51e-05	0.000964	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	6.44e-05	0.00275	CbGpPWpGaD
Estramustine—Chest pain—Doxorubicin—uterine cancer	6.42e-05	0.00095	CcSEcCtD
Estramustine—Anxiety—Doxorubicin—uterine cancer	6.4e-05	0.000947	CcSEcCtD
Estramustine—Anorexia—Epirubicin—uterine cancer	6.34e-05	0.000938	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	6.33e-05	0.0027	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	6.18e-05	0.00264	CbGpPWpGaD
Estramustine—Oedema—Doxorubicin—uterine cancer	6.16e-05	0.000911	CcSEcCtD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	6.13e-05	0.00261	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	6.1e-05	0.0026	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	6.09e-05	0.0026	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	6.08e-05	0.00259	CbGpPWpGaD
Estramustine—Thrombocytopenia—Doxorubicin—uterine cancer	6.03e-05	0.000892	CcSEcCtD
Estramustine—Insomnia—Epirubicin—uterine cancer	6.02e-05	0.00089	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	5.99e-05	0.00256	CbGpPWpGaD
Estramustine—Dyspnoea—Epirubicin—uterine cancer	5.93e-05	0.000877	CcSEcCtD
Estramustine—Anorexia—Doxorubicin—uterine cancer	5.87e-05	0.000868	CcSEcCtD
Estramustine—Decreased appetite—Epirubicin—uterine cancer	5.78e-05	0.000856	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	5.74e-05	0.00245	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	5.73e-05	0.00245	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	5.72e-05	0.00244	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	5.64e-05	0.00241	CbGpPWpGaD
Estramustine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	5.63e-05	0.0024	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	5.6e-05	0.00239	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	5.6e-05	0.00239	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	5.58e-05	0.00238	CbGpPWpGaD
Estramustine—Insomnia—Doxorubicin—uterine cancer	5.57e-05	0.000824	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	5.54e-05	0.00236	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	5.53e-05	0.00236	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	5.53e-05	0.00236	CbGpPWpGaD
Estramustine—Dyspnoea—Doxorubicin—uterine cancer	5.49e-05	0.000812	CcSEcCtD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	5.42e-05	0.00231	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	5.37e-05	0.00229	CbGpPWpGaD
Estramustine—Decreased appetite—Doxorubicin—uterine cancer	5.35e-05	0.000792	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	5.29e-05	0.00226	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	5.28e-05	0.00225	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—TP53—uterine cancer	5.2e-05	0.00222	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	5.18e-05	0.00221	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	5.16e-05	0.0022	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	5.16e-05	0.0022	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—EP300—uterine cancer	5.14e-05	0.00219	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	5.01e-05	0.00214	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.98e-05	0.00212	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.95e-05	0.00211	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—EP300—uterine cancer	4.92e-05	0.0021	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—CDKN2B—uterine cancer	4.88e-05	0.00208	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	4.87e-05	0.00208	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	4.72e-05	0.00201	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.71e-05	0.00201	CbGpPWpGaD
Estramustine—Pruritus—Epirubicin—uterine cancer	4.71e-05	0.000696	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.7e-05	0.00201	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PHF1—uterine cancer	4.66e-05	0.00199	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.58e-05	0.00195	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	4.56e-05	0.00195	CbGpPWpGaD
Estramustine—Diarrhoea—Epirubicin—uterine cancer	4.55e-05	0.000673	CcSEcCtD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	4.55e-05	0.00194	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	4.49e-05	0.00192	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—SMAD3—uterine cancer	4.46e-05	0.0019	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	4.39e-05	0.00187	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	4.38e-05	0.00187	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.37e-05	0.00186	CbGpPWpGaD
Estramustine—Pruritus—Doxorubicin—uterine cancer	4.35e-05	0.000644	CcSEcCtD
Estramustine—Vomiting—Epirubicin—uterine cancer	4.23e-05	0.000626	CcSEcCtD
Estramustine—Diarrhoea—Doxorubicin—uterine cancer	4.21e-05	0.000623	CcSEcCtD
Estramustine—Rash—Epirubicin—uterine cancer	4.19e-05	0.000621	CcSEcCtD
Estramustine—Dermatitis—Epirubicin—uterine cancer	4.19e-05	0.00062	CcSEcCtD
Estramustine—Headache—Epirubicin—uterine cancer	4.17e-05	0.000617	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.14e-05	0.00177	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—CHD4—uterine cancer	3.96e-05	0.00169	CbGpPWpGaD
Estramustine—Nausea—Epirubicin—uterine cancer	3.95e-05	0.000585	CcSEcCtD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	3.94e-05	0.00168	CbGpPWpGaD
Estramustine—Vomiting—Doxorubicin—uterine cancer	3.91e-05	0.000579	CcSEcCtD
Estramustine—Rash—Doxorubicin—uterine cancer	3.88e-05	0.000574	CcSEcCtD
Estramustine—Dermatitis—Doxorubicin—uterine cancer	3.88e-05	0.000574	CcSEcCtD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	3.88e-05	0.00165	CbGpPWpGaD
Estramustine—Headache—Doxorubicin—uterine cancer	3.86e-05	0.00057	CcSEcCtD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.69e-05	0.00157	CbGpPWpGaD
Estramustine—Nausea—Doxorubicin—uterine cancer	3.66e-05	0.000541	CcSEcCtD
Estramustine—ESR2—Generic Transcription Pathway—ESR1—uterine cancer	3.64e-05	0.00155	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—uterine cancer	3.52e-05	0.0015	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.52e-05	0.0015	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.47e-05	0.00148	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PGR—uterine cancer	3.43e-05	0.00146	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SUZ12—uterine cancer	3.32e-05	0.00142	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PGR—uterine cancer	3.28e-05	0.0014	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	3.25e-05	0.00139	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.23e-05	0.00138	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.22e-05	0.00137	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.22e-05	0.00137	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—HRAS—uterine cancer	3.19e-05	0.00136	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.13e-05	0.00133	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—EZH2—uterine cancer	3.11e-05	0.00133	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—AKT1—uterine cancer	3.04e-05	0.0013	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	3.02e-05	0.00129	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	3.01e-05	0.00129	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.92e-05	0.00125	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.86e-05	0.00122	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.83e-05	0.00121	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—AKT1—uterine cancer	2.81e-05	0.0012	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.79e-05	0.00119	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PTEN—uterine cancer	2.77e-05	0.00118	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.75e-05	0.00118	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.73e-05	0.00116	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.71e-05	0.00116	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.66e-05	0.00114	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.66e-05	0.00113	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.64e-05	0.00113	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.64e-05	0.00113	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.64e-05	0.00113	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.63e-05	0.00112	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.62e-05	0.00112	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.58e-05	0.0011	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.52e-05	0.00107	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.51e-05	0.00107	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.48e-05	0.00106	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—NRAS—uterine cancer	2.47e-05	0.00106	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	2.46e-05	0.00105	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.37e-05	0.00101	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—CDKN2B—uterine cancer	2.35e-05	0.001	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.31e-05	0.000986	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	2.25e-05	0.000959	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.24e-05	0.000954	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.2e-05	0.00094	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—SMAD3—uterine cancer	2.15e-05	0.000915	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	2.14e-05	0.000913	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KRAS—uterine cancer	2.13e-05	0.000909	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKR1B10—uterine cancer	2.1e-05	0.000896	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.09e-05	0.00089	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.96e-05	0.000836	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	1.96e-05	0.000835	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.95e-05	0.000833	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.93e-05	0.000824	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.9e-05	0.000812	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—HRAS—uterine cancer	1.81e-05	0.000772	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.77e-05	0.000757	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ESR1—uterine cancer	1.75e-05	0.000747	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RNF43—uterine cancer	1.74e-05	0.000742	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SRD5A2—uterine cancer	1.71e-05	0.000729	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NDUFB11—uterine cancer	1.71e-05	0.000729	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PGR—uterine cancer	1.65e-05	0.000705	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.65e-05	0.000703	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.63e-05	0.000695	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.61e-05	0.000686	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—AKT1—uterine cancer	1.6e-05	0.000682	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—INHBA—uterine cancer	1.59e-05	0.000679	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.58e-05	0.000673	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—EZH2—uterine cancer	1.57e-05	0.00067	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ESR2—uterine cancer	1.46e-05	0.000621	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.43e-05	0.000612	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKR1C1—uterine cancer	1.43e-05	0.000611	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.33e-05	0.000568	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.33e-05	0.000566	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.25e-05	0.000535	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKR1B1—uterine cancer	1.24e-05	0.000527	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—STAR—uterine cancer	1.24e-05	0.000527	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.22e-05	0.000521	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—CDKN2B—uterine cancer	1.18e-05	0.000505	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.17e-05	0.000497	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.1e-05	0.000471	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKR1C3—uterine cancer	1.1e-05	0.000471	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SMAD3—uterine cancer	1.08e-05	0.000462	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PGR—uterine cancer	1.08e-05	0.000459	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.05e-05	0.000449	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.05e-05	0.000449	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—YWHAE—uterine cancer	1.03e-05	0.000437	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FBXW7—uterine cancer	9.83e-06	0.000419	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—POLD1—uterine cancer	9.69e-06	0.000414	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.39e-06	0.0004	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKR1C1—uterine cancer	9.07e-06	0.000387	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.62e-06	0.000368	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STK11—uterine cancer	8.59e-06	0.000367	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.34e-06	0.000356	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—RRM2—uterine cancer	8.08e-06	0.000345	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SOCS3—uterine cancer	8.05e-06	0.000343	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—DCN—uterine cancer	7.85e-06	0.000335	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN2B—uterine cancer	7.7e-06	0.000329	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.61e-06	0.000325	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—STAR—uterine cancer	7.61e-06	0.000325	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IGF1R—uterine cancer	7.48e-06	0.000319	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP11A1—uterine cancer	7.39e-06	0.000315	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.05e-06	0.000301	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SMAD3—uterine cancer	7.03e-06	0.0003	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKR1C3—uterine cancer	6.98e-06	0.000298	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGFR2—uterine cancer	6.71e-06	0.000286	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—AKT1—uterine cancer	6.32e-06	0.000269	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—POLD1—uterine cancer	5.97e-06	0.000255	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.59e-06	0.000238	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—STK11—uterine cancer	5.44e-06	0.000232	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP19A1—uterine cancer	5.44e-06	0.000232	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCL2—uterine cancer	5.05e-06	0.000216	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—RRM2—uterine cancer	4.98e-06	0.000212	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—DCN—uterine cancer	4.83e-06	0.000206	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.55e-06	0.000194	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.3e-06	0.000183	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB2—uterine cancer	4.21e-06	0.00018	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MTHFR—uterine cancer	4.09e-06	0.000174	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL8—uterine cancer	4e-06	0.00017	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN1B—uterine cancer	3.9e-06	0.000166	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CTNNB1—uterine cancer	3.69e-06	0.000157	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTEN—uterine cancer	3.59e-06	0.000153	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EP300—uterine cancer	3.43e-06	0.000146	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—STK11—uterine cancer	3.35e-06	0.000143	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.35e-06	0.000143	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—uterine cancer	3.25e-06	0.000138	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NRAS—uterine cancer	3.21e-06	0.000137	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—AKT1—uterine cancer	3.18e-06	0.000136	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KRAS—uterine cancer	2.76e-06	0.000118	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CA—uterine cancer	2.53e-06	0.000108	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MTHFR—uterine cancer	2.52e-06	0.000107	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—uterine cancer	2.45e-06	0.000105	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HRAS—uterine cancer	2.35e-06	0.0001	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTEN—uterine cancer	2.27e-06	9.7e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—EP300—uterine cancer	2.17e-06	9.25e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT1—uterine cancer	2.07e-06	8.83e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CA—uterine cancer	1.6e-06	6.84e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTEN—uterine cancer	1.4e-06	5.97e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—EP300—uterine cancer	1.34e-06	5.7e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKT1—uterine cancer	1.31e-06	5.59e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CA—uterine cancer	9.88e-07	4.22e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKT1—uterine cancer	8.07e-07	3.44e-05	CbGpPWpGaD
